EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The relation between observer-rated depressive symptoms and patient-rated quality of life after six weeks of antidepressant treatment: pooled patient-level analysis of mirtazapine trials

Helena Werin Sjögren, Evana López, Alexander Lisinski iD, Mikael Landén, Johan Lundberg, Fredrik Hieronymus iD

BJPsych Open · 2026-07 · 12 (4)

DOI: 10.1192/bjo.2026.12002 ↗

Kurz gefasst

Fachartikel in der Zeitschrift BJPsych Open, online erschienen am 09.06.2026. Verfasst von Helena Werin Sjögren und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, https://ror.org/01tm6cn81Institute of Neuroscience and Physiology, University of Gothenburg, Sweden. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The primary effect parameter in depression trials is usually a measure of depressive symptoms, e.g. the Hamilton Depression Rating Scale (HDRS). Such measures have been criticised for not covering patient-relevant domains, such as quality of life, and hence not accurately reflecting patient-experienced efficacy.

Aims

To investigate the relation between clinician-rated depressive symptoms and patient-reported quality of life measured by the Quality-of-Life Enjoyment and Satisfaction Questionnaire Short Form (Q-LES-Q-SF).

Method

We included data from six acute-phase trials ( n = 918) comparing mirtazapine to another antidepressant (amitriptyline, fluoxetine, paroxetine or venlafaxine) where both HDRS and Q-LES-Q-SF had been administered. No study included a placebo arm. Correlations between instruments (scales, subscales and items) were assessed after six weeks. Q-LES-Q-SF outcomes for participants who were in HDRS-defined remission were contrasted to those from participants with more severe depressive symptoms.

Results

Q-LES-Q-SF ratings correlated strongly with HDRS-17 ( r = −0.73, p < 0.0001) and HDRS-6 ( r = −0.72, p < 0.0001), but somewhat weaker to HDRS-11 ( r = −0.64, p < 0.0001). Depressed mood ( r = −0.66, p < 0.0001) and work and activities ( r = −0.65, p < 0.0001) showed the strongest item-level correlations to Q-LES-Q-SF. Participants in HDRS-remission had average Q-LES-Q-SF scores on the lower end of those reported by healthy controls, whereas patients with mild depressive symptoms (or worse) had average life-quality scores corresponding to severe impairment.

Conclusions

HDRS and Q-LES-Q-SF showed considerable agreement in depressed study participants treated with antidepressants, suggesting that HDRS meaningfully reflects patient-reported improvement.

Schlagwörter

Stichwörter der Autor:innen

Depressive disordersantidepressantsclinical outcomes measuresmeta-analysisquality of life

Autor:innen und Institutionen

  • Department of Pharmacology, https://ror.org/01tm6cn81Institute of Neuroscience and Physiology, University of Gothenburg, Sweden.
  • Department of Clinical Neuroscience, Karolinska Institute, Stockholm, Sweden.
  • Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, University of Gothenburg, Sweden.
  • Department of Medical Epidemiology and Biostatistics, Karolinska Institute, Stockholm, Sweden.
  • Department of Clinical Medicine, https://ror.org/01aj84f44Aarhus University, Denmark.

ORCID-Profile: Alexander Lisinski, Fredrik Hieronymus

Zitieren

APA

Sjögren, H. W., López, E., Lisinski, A., Landén, M., Lundberg, J., & Hieronymus, F. (2026). The relation between observer-rated depressive symptoms and patient-rated quality of life after six weeks of antidepressant treatment: pooled patient-level analysis of mirtazapine trials. BJPsych Open, 12(4). https://doi.org/10.1192/bjo.2026.12002

Vancouver

Sjögren HW, López E, Lisinski A, Landén M, Lundberg J, Hieronymus F. The relation between observer-rated depressive symptoms and patient-rated quality of life after six weeks of antidepressant treatment: pooled patient-level analysis of mirtazapine trials. BJPsych Open. 2026;12(4). doi:10.1192/bjo.2026.12002

BibTeX
@article{Sjgren2026,
  author = {Sjögren, Helena Werin and López, Evana and Lisinski, Alexander and Landén, Mikael and Lundberg, Johan and Hieronymus, Fredrik},
  title = {The relation between observer-rated depressive symptoms and patient-rated quality of life after six weeks of antidepressant treatment: pooled patient-level analysis of mirtazapine trials},
  journal = {BJPsych Open},
  year = {2026},
  volume = {12},
  number = {4},
  doi = {10.1192/bjo.2026.12002}
}
Kostenlos starten →